The Institute aims to maximise the impact of its research through Knowledge Exchange and Commercialisation (KEC) in order to translate research into action for social and economic benefit. A key part of our KEC strategy is to partner with industry, particularly biotech and pharma companies, to translate our research and support the bioeconomy.
We benefit from being co-located with around 60 biomedical companies on the Babraham Research Campus, and collaborate extensively with these organisations. Babraham Institute Enterprise Ltd (BIE) supports the commercialisation of the Institute’s research and access to our core science services.
Commercialisation of Institute research and access to Institute facilities is the responsibility of the Commercialisation Manager.